Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Biomaterials. 2008 Feb 7;29(13):2113–2124. doi: 10.1016/j.biomaterials.2007.12.048

Figure 9.

Figure 9

Swelling of dissolving microneedle patch backing layer after insertion into skin using a Franz cell. (a) A patch of CMC pyramidal microneedles containing sulforhodamine inserted into skin for 15 h shows extensive swelling of the backing layer. (b) A backing layer of CMC that contains no microneedles (negative control) placed on the surface of skin for 15 h shows little swelling. Human epidermis was used. Imaging was by brightfield microscopy.